Stoke Therapeutics, Inc. (STOK) Form 10-K Annual Reports
Stoke Therapeutics, Inc. (STOK) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: STOK
CIK: 1623526
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
KPMG LLP
Auditor SinceSince 12/31/2018 12:00:00 AM
Lead Engagement PartnerAndrew Jacober
Audit LocationBoston, Massachusetts, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 4 | 2026-10-02 | 2026-10-02 | 4 Filing | 0001966716-26-000014 | View SEC Doc Filr Page |
| 4 | 2026-10-02 | 2026-10-01 | 4 Filing | 0001780088-26-000023 | View SEC Doc Filr Page |
| 144 | 2026-10-02 | — | 144 Filing | 0001950047-26-010004 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-09-30 | — | SCHEDULE 13G Filing | 0000921895-26-002685 | View SEC Doc Filr Page |
| 4 | 2026-09-25 | 2026-09-23 | 4 Filing | 0001685994-26-000009 | View SEC Doc Filr Page |
| 3 | 2026-09-25 | 2026-09-23 | 3 Filing | 0001685994-26-000007 | View SEC Doc Filr Page |
| 8-K | 2026-09-25 | 2026-09-22 | 8-K | 0001193125-26-402820 | View SEC Doc Filr Page |
| 4 | 2026-09-03 | 2026-09-01 | 4 Filing | 0001780088-26-000021 | View SEC Doc Filr Page |
| 4 | 2026-08-18 | 2026-08-14 | 4 Filing | 0001780088-26-000019 | View SEC Doc Filr Page |
| 4 | 2026-08-18 | 2026-08-14 | 4 Filing | 0001522780-26-000007 | View SEC Doc Filr Page |
| 4 | 2026-08-18 | 2026-08-14 | 4 Filing | 0001966716-26-000012 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0000902664-26-003525 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-12 | — | SCHEDULE 13G/A Filing | 0000947263-26-000071 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-06 | — | SCHEDULE 13G/A Filing | 0000315066-26-002141 | View SEC Doc Filr Page |
| 4 | 2026-08-05 | 2026-08-03 | 4 Filing | 0001780088-26-000017 | View SEC Doc Filr Page |
| 8-K | 2026-08-03 | 2026-08-03 | 8-K | 0001193125-26-330804 | View SEC Doc Filr Page |
| 424B5 | 2026-08-03 | — | 424B5 | 0001193125-26-330792 | View SEC Doc Filr Page |
| 144 | 2026-08-03 | — | 144 Filing | 0001950047-26-007565 | View SEC Doc Filr Page |
| S-8 | 2026-08-03 | — | S-8 | 0001193125-26-330706 | View SEC Doc Filr Page |
| 10-Q | 2026-08-03 | 2026-06-30 | 10-Q | 0001193125-26-330557 | View SEC Doc Filr Page |
| 8-K | 2026-08-03 | 2026-08-03 | 8-K | 0001193125-26-330537 | View SEC Doc Filr Page |
| 4 | 2026-07-17 | 2026-07-16 | 4 Filing | 0001404955-26-000006 | View SEC Doc Filr Page |
| 4 | 2026-07-17 | 2026-07-15 | 4 Filing | 0001858760-26-000008 | View SEC Doc Filr Page |
| 3 | 2026-07-17 | 2026-07-13 | 3 Filing | 0001858760-26-000007 | View SEC Doc Filr Page |
| 4 | 2026-07-06 | 2026-07-01 | 4 Filing | 0001780088-26-000015 | View SEC Doc Filr Page |